The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection

2009 ◽  
Vol 99 (6) ◽  
pp. 335-342 ◽  
Author(s):  
Sae Byeol Choi ◽  
Seung Woo Park ◽  
Kyung Sik Kim ◽  
Jin Sub Choi ◽  
Woo Jung Lee
Surgery ◽  
2005 ◽  
Vol 137 (4) ◽  
pp. 396-402 ◽  
Author(s):  
Yoshihiro Sakamoto ◽  
Tomoo Kosuge ◽  
Kazuaki Shimada ◽  
Tsuyoshi Sano ◽  
Hidenori Ojima ◽  
...  

2013 ◽  
Vol 85 (5) ◽  
pp. 212 ◽  
Author(s):  
Young Jae Chung ◽  
Dong Wook Choi ◽  
Seong Ho Choi ◽  
Jin Seok Heo ◽  
Dong Hun Kim

Pancreatology ◽  
2019 ◽  
Vol 19 ◽  
pp. S32-S33
Author(s):  
Christine Tjaden ◽  
Ulf Hinz ◽  
Ulla Klaiber ◽  
Ulrike Heger ◽  
John P. Neoptolemos ◽  
...  

Chemotherapy ◽  
2016 ◽  
Vol 61 (3) ◽  
pp. 152-158 ◽  
Author(s):  
Hee Seung Lee ◽  
Sang Hoon Lee ◽  
Yun Ho Roh ◽  
Moon Jae Chung ◽  
Jeong Youp Park ◽  
...  

Background: Surgical resection is the only curative treatment for extrahepatic bile duct cancer. Additionally, the recurrence rate after curative surgery is relatively high, requiring adjuvant therapy. However, the efficacy of adjuvant chemotherapy compared with surgery alone has not yet been clarified. This study aimed to evaluate the efficacy of adjuvant chemotherapy and identify prognostic factors influencing survival in extrahepatic bile duct cancer patients who underwent curative surgical resection. Methods: Ninety-seven patients with extrahepatic bile duct cancer who underwent curative resection between January 2005 and December 2010 were retrospectively analyzed. Results: Among the 97 patients, 31 underwent adjuvant chemotherapy and 66 did not. The 5-year overall survival rate was 34% for patients who underwent adjuvant chemotherapy. There was no significant difference for overall survival between patients who underwent adjuvant chemotherapy and those who did not (p = 0.228). On multivariate analysis, postoperative carbohydrate antigen 19-9 levels and histologic grade were independent prognostic factors related to long-term survival (p < 0.05). Conclusions: Postoperative adjuvant chemotherapy did not improve survival after surgical resection for extrahepatic bile duct cancer.


2011 ◽  
Vol 77 (11) ◽  
pp. 1445-1448 ◽  
Author(s):  
Qi-Lu Qiao ◽  
Tai-Ping Zhang ◽  
Jun-Chao Guo ◽  
Han-Xiang Zhan ◽  
Jian-Xun Zhao ◽  
...  

Prognostic factors influencing long-term survival after radical resection for distal bile duct cancer have not been well established because of the rarity of this malignancy. The goal of this study was to identify main prognostic factors in patients undergoing pancreatoduodenectomy for distal bile duct carcinoma. A retrospective study consisting of 122 patients with distal bile duct cancer who underwent pancreatoduodenectomy in three major university hospitals was performed to identify the main prognostic factors. Major surgical complications occurred in 40 patients (32.8%), of whom eight died (6.6%) in the hospital. Overall actuarial survival (excluding hospital deaths) at 1-, 3-, and 5-year follow-up was 82.9, 49.4, and 32.7 per cent, respectively, with a median survival of 36 months. Univariate analysis showed that papillary tumor ( P = 0.045), negative surgical margin (R0 resection, P = 0.005), earlier pT ( P = 0.005), pTNM stage ( P < 0.001), and absence of lymph node involvement ( P < 0.0001) were significant predictors of survival. On multivariate analysis, only lymph node metastasis was shown to be an independent prognostic factor of survival ( P = 0.036). Lymph node involvement was the most important survival predictor after a Whipple resection in patients with distal cholangiocarcinoma.


2012 ◽  
Vol 38 (11) ◽  
pp. 1043-1050 ◽  
Author(s):  
E. Pomianowska ◽  
K. Grzyb ◽  
A. Westgaard ◽  
O.P.F. Clausen ◽  
I.P. Gladhaug

1995 ◽  
Vol 88 ◽  
pp. S125
Author(s):  
C. Prasad ◽  
T. P. Wade ◽  
K. S. Virgo ◽  
F. E. Johnson

Sign in / Sign up

Export Citation Format

Share Document